Last reviewed · How we verify

AZELASTINE HYDROCHLORIDE

FDA-approved approved Small molecule ✓ Verified May 2026 Quality 5/100

AZELASTINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 1996).

Azelastine hydrochloride is used to treat conditions such as allergic rhinitis, seasonal allergic rhinitis, and seasonal allergic conjunctivitis. It is available in various formulations, including nasal sprays, often in combination with other medications like fluticasone propionate.

At a glance

Generic nameAZELASTINE HYDROCHLORIDE
ModalitySmall molecule
PhaseFDA-approved
First approval1996

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about AZELASTINE HYDROCHLORIDE

What is AZELASTINE HYDROCHLORIDE?

AZELASTINE HYDROCHLORIDE is a Small molecule drug.

When was AZELASTINE HYDROCHLORIDE approved?

AZELASTINE HYDROCHLORIDE was first approved on 1996.

What development phase is AZELASTINE HYDROCHLORIDE in?

AZELASTINE HYDROCHLORIDE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing